Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-18 · accession 0001209191-21-066004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-11-22 | 2021-11-18 | AXSM | Coleman Mark | Dir | P - Purchase | $35.09 | +1,430 | 421.4K | +0.3% | +$50.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | P | A | 1,021 | $35.10 | 422,428 | I See Footnote | — | — | (F1) Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares. |
| 2 | Common | Common Stock | 2021-11-18 | P | A | 409 | $35.07 | 421,407 | I See Footnote | — | — | (F1) Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares. |